No Data
No Data
Health Catalyst(HCAT.US) Officer Sells US$19,281.09 in Common Stock
$Health Catalyst(HCAT.US)$ Officer Alger Jason sold 2,823 shares of common stock on Jun 12, 2024 at an average price of $6.83 for a total value of $19,281.09.Source: Announcement What is statement of
Health Catalyst(HCAT.US) Officer Sells US$16,017.96 in Common Stock
$Health Catalyst(HCAT.US)$ Officer Landry Benjamin sold 2,387 shares of common stock on Jun 6, 2024 at an average price of $6.7105 for a total value of $16,017.96.Source: Announcement What is statemen
Health Catalyst(HCAT.US) Officer Sells US$49,008 in Common Stock
$Health Catalyst(HCAT.US)$ Officer Freeman Kevin Lee sold 7,500 shares of common stock on Jun 11, 2024 at an average price of $6.5344 for a total value of $49,008.Source: Announcement What is statemen
Health Catalyst(HCAT.US) Officer Sells US$80,064.14 in Common Stock
$Health Catalyst(HCAT.US)$ Officer LeSueur Daniel sold 11,923 shares of common stock on Jun 6, 2024 at an average price of $6.7151 for a total value of $80,064.14.Source: Announcement What is statemen
Wells Fargo Maintains Health Catalyst(HCAT.US) With Buy Rating, Maintains Target Price $13
Wells Fargo analyst Stan Berenshteyn maintains $Health Catalyst(HCAT.US)$ with a buy rating, and maintains the target price at $13.According to TipRanks data, the analyst has a success rate of 55.8% a
Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
Throughout the last three months, 4 analysts have evaluated Health Catalyst (NASDAQ:HCAT), offering a diverse set of opinions from bullish to bearish.The table below summarizes their recent ratings, s
No Data